Tang Xuan, Zhou Fengjin, Wang Sicheng, Wang Guangchao, Bai Long, Su Jiacan
Organoid Research Center, Institute of Translational Medicine, Shanghai University, Shanghai 200444, China; National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai 200444, China.
Department of Orthopaedics, Honghui Hospital, Xi'an Jiao Tong University, Xi'an 710000, China.
J Adv Res. 2024 Nov 5. doi: 10.1016/j.jare.2024.10.032.
The effective regeneration of bone/cartilage defects remains a significant clinical challenge, causing irreversible damage to millions annually.Conventional therapies such as autologous or artificial bone grafting often yield unsatisfactory outcomes, emphasizing the urgent need for innovative treatment methods. Biomaterial-based strategies, including hydrogels and active scaffolds, have shown potential in promoting bone/cartilage regeneration. Among them, injectable hydrogels have garnered substantial attention in recent years on account of their minimal invasiveness, shape adaptation, and controlled spatiotemporal release. This review systematically discusses the synthesis of injectable hydrogels, bioinspired approaches-covering microenvironment, structural, compositional, and bioactive component-inspired strategies-and their applications in various bone/cartilage disease models, highlighting bone/cartilage regeneration from an innovative perspective of bioinspired design. Taken together, bioinspired injectable hydrogels offer promising and feasible solutions for promoting bone/cartilage regeneration, ultimately laying the foundations for clinical applications. Furthermore, insights into further prospective directions for AI in injectable hydrogels screening and organoid construction are provided.
骨/软骨缺损的有效再生仍然是一项重大的临床挑战,每年对数以百万计的人造成不可逆转的损害。自体骨移植或人工骨移植等传统疗法往往效果不尽人意,这凸显了对创新治疗方法的迫切需求。基于生物材料的策略,包括水凝胶和活性支架,在促进骨/软骨再生方面已显示出潜力。其中,可注射水凝胶近年来因其微创性、形状适应性和可控的时空释放而备受关注。本文综述系统地讨论了可注射水凝胶的合成、受生物启发的方法——涵盖微环境、结构、组成和生物活性成分启发的策略——及其在各种骨/软骨疾病模型中的应用,从受生物启发设计的创新角度突出骨/软骨再生。综上所述,受生物启发的可注射水凝胶为促进骨/软骨再生提供了有前景且可行的解决方案,最终为临床应用奠定基础。此外,还提供了关于人工智能在可注射水凝胶筛选和类器官构建方面进一步前瞻性方向的见解。